Comparison of Antidiabetic Medications during the Treatment of Atherosclerosis in T2DM Patients
Type 2 diabetes is often associated with arterial atherosclerosis in large blood vessels. We set out to elucidate whether commonly used antidiabetic drugs metformin, sitagliptin, and pioglitazone will reduce atherosclerosis in T2DM patients. We enrolled 176 individuals with type 2 diabetes, which we...
Saved in:
Main Authors: | Xiaojie Liu (Author), Tao Mei (Author), Wei Chen (Author), Shandong Ye (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of metformin on blood and urine pro-inflammatory mediators in patients with type 2 diabetes
by: Wei Chen, et al.
Published: (2016) -
Persepsi Pasien DM Tipe 2 Terhadap Penggunaan Obat Antidiabetes Oral di RSUP Dr. Hasan Sadikin Bandung
by: Eko Kuncoro Manunggaling Gusti, et al.
Published: (2020) -
A Review of Economic Models Submitted to NICE's Technology Appraisal Programme, for Treatments of T1DM & T2DM
by: Marie-Josée Daly, et al.
Published: (2022) -
Association between sociodemographic status and the T2DM-related risks in China: implication for reducing T2DM disease burden
by: Xin Huang, et al.
Published: (2024) -
Booklet handout to improve glycemic control in type-2-DM patients and comparison with other models
by: Daniek Viviandhari, et al.
Published: (2021)